Vincerx Pharma, Inc. - VINC
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q1 2025
· Q4 2024
Value (USD)
Total reported value ($000)
$62K
QoQ value delta ($000)
-$493K
(-88.83%)
Implied price effect (QoQ)
+92.46%
Shares
Total shares
124,403
QoQ shares delta
-2,018,860
(-94.2%)
Total shares held by funds (by quarter)
Market chart (VINC)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q1 2025)
Top 25 only
Full list
Early Q2 2025 data: only 1 institutional holders reported so far. More will appear as funds file with the SEC.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| CITADEL ADVISORS LLC | 22 | 42,777 | 0.0% |
| GOLDMAN SACHS GROUP INC | 16 | 31,567 | 0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 10 | 19,285 | 0.0% |
| VANGUARD GROUP INC | 7 | 14,317 | 0.0% |
| MILLENNIUM MANAGEMENT LLC | 5 | 10,798 | 0.0% |
| Tower Research Capital LLC (TRC) | 1 | 2,997 | 0.0% |
| BlackRock, Inc. | 1 | 2,352 | 0.0% |
| JPMORGAN CHASE & CO | 0 | 1 | 0.0% |
| BANK OF AMERICA CORP /DE/ | 0 | 15 | 0.0% |
| MORGAN STANLEY | 0 | 102 | 0.0% |
| UBS Group AG | 0 | 142 | 0.0% |
| SBI Securities Co., Ltd. | 0 | 50 | 0.0% |